<DOC>
	<DOCNO>NCT00930644</DOCNO>
	<brief_summary>This study 2-year open label extension study collect long term efficacy safety data patient complete 24-weeks study drug dose CL0600-020 .</brief_summary>
	<brief_title>Open-Label Study Teduglutide Subjects With PN-Dependent Short Bowel Syndrome ( SBS )</brief_title>
	<detailed_description>Some people SBS need infuse parenteral nutrition ( PN ) order live . Although PN save life , lead serious side effect infection liver damage . The risk effect increase long people PN . Teduglutide investigative medicine evaluate possible treatment people PN-dependent SBS . Teduglutide similar protein body make . When people SBS , body make enough protein trouble get nutrient fluid food eat drink . We want see teduglutide help decrease amount PN need body well job take eats drink . We also want find safe teduglutide record side effect .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Short Bowel Syndrome</mesh_term>
	<criteria>must complete 24 week dose CL0600020 study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>short bowel syndrome</keyword>
	<keyword>parenteral nutrition</keyword>
	<keyword>PN</keyword>
	<keyword>HPN</keyword>
	<keyword>TPN</keyword>
	<keyword>SBS</keyword>
</DOC>